A mom’s Stage IV cancer had no symptoms. An innovative surgery saved her life.

A Mother’s Silent Battle: Innovative Liver Transplant Offers New Hope for Stage IV Colorectal Cancer

A mom s Stage IV cancer – In May 2024, Amy Piccoli’s son returned home from school with a stomach bug. As a mother of three, she was no stranger to seasonal illnesses, but this time, her symptoms took an unexpected turn. Despite the initial expectation of a routine infection, Piccoli soon found herself severely dehydrated, prompting a trip to the emergency room. What began as a simple health concern quickly revealed a more alarming truth.

Unseen Threat: A Diagnosis Without Warning

During her ER visit, doctors conducted a CT scan that detected unusual spots on her liver and a mass in her colon. A follow-up MRI confirmed the findings, leading to a biopsy. The results, delivered in a moment of profound disorientation, stunned Piccoli. “My doctor called me and said, ‘We think that the liver spots are cancer that has spread from the colon,’” she recalled in a

“I was in complete shock. I had no symptoms… I have no family history of any type of cancer.”

By the Friday prior to Memorial Day, the Stage IV colon cancer diagnosis was confirmed. The revelation left Piccoli and her husband in a state of emotional turmoil. “I was just in total shock, and panicked and scared,” she said. “My entire life, I’ve been a very diligent person with regards to going to the doctor and noticing changes in my body… I did everything. So to not have caught this at some earlier stage was just unfathomable to me.”

Rare Case of Asymptomatic Stage IV Colorectal Cancer

Dr. Robin Mendelsohn, a gastroenterologist at Memorial Sloan Kettering Cancer Center, highlighted the unusual nature of Piccoli’s case. “In most cases, colon cancer presents with symptoms like gastrointestinal distress, blood in the stool, and unexplained weight loss,” she explained. “A diagnosis of late-stage colorectal cancer after no symptoms is extremely rare.”

Mendelsohn noted that subtle indicators such as fatigue might go unnoticed, making early detection even more challenging. Piccoli’s journey took a critical turn in June 2024 when she began treatment. Genetic testing revealed that immunotherapy could target her tumors, and the therapy was incorporated into her regimen the following month. “The combination of two medications worked incredibly well and led to significant shrinkage in the tumors,” she said, adding that this progress enabled surgeons to excise the colon mass.

Transplant as a Life-Saving Option

However, the liver tumors remained a persistent challenge. Traditional surgery could not remove them, so Piccoli sought an alternative. She turned to an online resource that introduced her to the concept of liver transplants for patients with advanced colorectal cancer. “I asked my oncologist about something I’d seen online: Liver transplants for patients like me,” she shared.

Dr. Zachary Dietch, a transplant surgeon at Northwestern Medicine, emphasized the rarity of this approach. “Continuing to treat the liver tumors with chemotherapy alone would leave Piccoli with only about a 10% chance of surviving more than five years,” he stated. Yet, recent European studies suggested a dramatic shift in prognosis. “Some patients who have the cancerous part of their colon removed and receive a liver transplant can see five-year survival rates jump to as high as 80%,” added Dr. Satish Nadig, director of Northwestern’s Comprehensive Transplant Center.

The procedure requires strict criteria, including a low risk of cancer recurrence and confirmation that the disease is confined to the liver. “Only a minority of patients will fit those descriptors,” Mendelsohn noted. Additionally, doctors must evaluate the tumors’ characteristics. For those who qualify, the transplant becomes a transformative option. “Because the treatment is so new, just a few centers in the U.S. perform it,” Nadig said. “It turns hospice into hope.”

The Path to Transplant: A Family’s Support

After her diagnosis, Piccoli’s oncologist referred her to the Northwestern Medicine program, which Nadig oversees. In September 2025, she traveled to Chicago for an evaluation that deemed her a suitable candidate for a transplant from a living donor. Over a dozen friends and family members completed forms to determine compatibility. A family friend, Lauren Prior, emerged as the ideal match.

“I was just so excited for the surgery. I was excited for a transplant. I had no fear around such a major surgery,” Piccoli said. “I knew I would be cancer-free.”

Recovery and Renewed Life

The operation in December 2025 marked a pivotal moment. “The surgeries went smoothly,” Dietch remarked. Piccoli spent three months in Chicago recovering, adjusting to anti-rejection medications and undergoing frequent scans to monitor her condition. While being away from her family was difficult, regular visits provided emotional support. “It was hard, it was hard on everyone, but at the end of the day, I did,” she said, reflecting on the experience.

Today, Piccoli describes the outcome as a “new lease on life.” The transplant not only eradicated her cancer but also restored her ability to engage in daily activities without constant worry. Her story underscores the importance of innovative treatments for patients whose cancer develops silently. “This case highlights how medical advancements can change outcomes,” Nadig explained. “It’s not just about surviving; it’s about living with hope.”

As Piccoli navigates her post-transplant journey, she remains grateful for the support of her family and the expertise of her medical team. Her experience also serves as a reminder of the complexities of colorectal cancer, particularly in its advanced stages. While the disease often manifests with recognizable symptoms, cases like hers demonstrate the critical role of early detection and cutting-edge therapies in extending survival. For Piccoli, the liver transplant was more than a procedure—it was a second chance at a life free from the shadow of cancer.

Dr. Dietch noted that the success of such transplants depends on a multidisciplinary approach, combining surgery, immunotherapy, and ongoing monitoring. “It’s a collaborative effort,” he said. “Each step, from diagnosis to transplant, requires precision and optimism.” Piccoli’s case has become a beacon of hope for others facing similar challenges, proving that even in the face of a seemingly insurmountable diagnosis, innovation can pave the way for recovery.

Her journey from a stomach bug to a life-saving transplant exemplifies the power of medical research and patient resilience. While the road was fraught with uncertainty, the combination of diligence, advanced treatment, and a supportive network led to a remarkable outcome. For patients with asymptomatic Stage IV colorectal cancer, Piccoli’s story may inspire a renewed sense of possibility, offering proof that hope can be found in unexpected places.